The role of the natriuretic peptides in the cardiovascular system

Cardiovascular Research

Volumn 51, Issue 3, 2001, Pages 489-494

  Suzuki, Toru ^a   Yamazaki, Tsutomu ^a   Yazaki, Yoshio ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

Antihypertensive diuretic agents; Hemodynamics; Hormones; Natriuretic peptide; Receptors

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; NATRIURETIC PEPTIDE TYPE C; NEUROHORMONE; VASOPRESSIN;

CARDIOVASCULAR SYSTEM; GENETIC MODEL; HEART; HORMONE INHIBITION; HUMAN; KIDNEY; NATRIURESIS; NEUROENDOCRINE SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN STRUCTURE; REGULATORY MECHANISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; VASODILATATION;

ANIMALS; ATRIAL NATRIURETIC FACTOR; CARDIOVASCULAR PHYSIOLOGY; DISEASE MODELS, ANIMAL; HUMANS; NATRIURESIS; NATRIURETIC PEPTIDE, BRAIN; NATRIURETIC PEPTIDE, C-TYPE; PEPTIDES;

EID: 0035882414     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(01)00238-3     Document Type: Review

References (60)

1. Electron microscopy of the atrium of the heart
2. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats
3. Heart atria granularity effects of changes in water-electrolyte balance
4. Bioactive cardiac substances: Potent vasorelaxant activity in mammalian atria
5. Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (alpha-hANP)
6. The amino acid sequence of an atrial peptide with potent diuretic and natriuretic properties
7. A new natriuretic peptide in porcine brain
8. C-type natriuretic peptide (CNP): A new member of natriuretic peptide family identified in porcine brain
9. Identification of rat gamma atrial natriuretic polypeptide and characterization of the cDNA encoding its precursor
10. Cloning and sequence analysis of cDNA encoding a precursor for human atrial natriuretic polypeptide
11. mRNA sequence for human cardiodilatin-atrial natriuretic factor precursor and regulation of precursor mRNA in rat atria
12. Cloning and sequence analysis of the cDNA for the rat atrial natriuretic factor precursor
13. Structure of rat atrial natriuretic factor precursor deduced from cDNA sequence
14. Molecular cloning and characterization of DNA sequences encoding rat and human atrial natriuretic factors
15. Isolation and sequence determination of rat cardiac natriuretic peptide
16. Cloning and sequence analysis of cDNA encoding a precursor for rat brain natriuretic peptide
17. Cloning and sequence analysis of cDNA encoding a precursor for human brain natriuretic peptide
18. Gene and precursor structure of porcine C-type natriuretic peptide
19. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an 'emergency' cardiac hormone against ventricular overload
20. Co-purification of an atrial natriuretic factor receptor and particulate guanylate cyclase from rat lung
21. Purification of atrial natriuretic peptide receptor from bovine lung. Evidence for a disulfide-linked subunit structure
22. Purification and subunit composition of atrial natriuretic peptide receptor
23. Physiological role of silent receptors of atrial natriuretic factor
24. Atrial natriuretic peptide clearance receptor. Complete sequence and functional expression of cDNA clones
25. A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor
26. Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclases
27. G(i-1)/G(i-2)-dependent signaling by single-transmembrane natriuretic peptide clearance receptor
28. Identification of the G protein-activating domain of the natriuretic peptide clearance receptor (NPR-C)
29. Atrial natriuretic peptide clearance receptor participates in modulating endothelial permeability
30. Characterization by affinity cross-linking of a receptor for atrial natriuretic peptide in cultured human thyroid cells associated with reductions in both adenosine 3′,5′-monophosphate production and thyroglobulin secretion
31. The presence of atrial-natriuretic-factor receptors of ANF-R2 subtype in rat platelets. Coupling to adenylate cyclase/cyclic AMP signal-transduction system
32. The natriuretic peptide system in the brain: Implications in the central control of cardiovascular and neuroendocrine functions
33. Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis
34. Cardiorenal and neurohormonal effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase-coupled receptors
35. Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: Beneficial effects on left ventricular function
36. Augmented expression of atrial natriuretic polypeptide gene in ventricles of spontaneously hypertensive rats (SHR) and SHR-stroke prone
37. Identification of atrial natriuretic factor within ventricular tissue in hamsters and humans with congestive heart failure
38. Ventricles as a major site of atrial natriuretic factor synthesis and release in cardiomyopathic hamsters with heart failure
39. Hypotension in transgenic mice expressing atrial natriuretic factor fusion genes
40. Hemodynamics in transgenic mice with overexpression of atrial natriuretic factor
41. Molecular cloning of the complementary DNA and gene that encode mouse brain natriuretic peptide and generation of transgenic mice that overexpress the brain natriuretic peptide gene
42. Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension
43. Cardiac fibrosis in mice lacking brain natriuretic peptide
44. Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide
45. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure
46. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure
47. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction
48. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure; prognostic role of plasma Brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction
49. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care
50. Biochemical detection of left-ventricular systolic dysfunction
51. Evaluation of plasma natriuretic peptides as markers for left ventricular dysfunction
52. Superiority of Brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy
53. Elevated B-type natriuretic peptide levels after anthracycline administration
54. Screening for cardiac dysfunction in asymptomatic patients by measuring B-type natriuretic peptide levels
55. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction
56. Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction
57. New insights into the cardiac natriuretic peptides
58. The natriuretic-peptide family
59. Natriuretic peptides